When: Active Now

Where: Be Well Clinical Studies

Location: Lincoln, Nebraska

Who is eligible?

• Infants that are 2 months old

This clinical study does not require blood samples.

The vaccine and study-related procedures are provided at no cost to you.

As a parent you want to make good decisions for your baby.

This includes protection against pneumococcal disease. Pneumococcal disease is caused by bacteria and can lead to serious symptoms like meningitis, sepsis, and pneumonia. Children younger than 2 years of age are among those most at risk.

We are seeking infants who are 2 months of age to participate in a clinical study called skysavi-5 that is helping us to learn more about the safety of a new investigational pneumococcal vaccine.